These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 29324534)
1. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group. Cioffi R; Bergamini A; Gadducci A; Cormio G; Giorgione V; Petrone M; Rabaiotti E; Pella F; Candiani M; Mangili G Int J Gynecol Cancer; 2018 Feb; 28(2):332-337. PubMed ID: 29324534 [TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France. Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886 [TBL] [Abstract][Full Text] [Related]
3. The added value of hysterectomy in the management of gestational trophoblastic neoplasia. Eysbouts YK; Massuger LFAG; IntHout J; Lok CAR; Sweep FCGJ; Ottevanger PB Gynecol Oncol; 2017 Jun; 145(3):536-542. PubMed ID: 28390821 [TBL] [Abstract][Full Text] [Related]
4. Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia. Wong JM; Liu D; Lurain JR J Reprod Med; 2014; 59(5-6):204-8. PubMed ID: 24937958 [TBL] [Abstract][Full Text] [Related]
5. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13. Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171 [TBL] [Abstract][Full Text] [Related]
6. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study. Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884 [TBL] [Abstract][Full Text] [Related]
7. Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause. Savage P; Cooke R; O'Nions J; Krell J; Kwan A; Camarata M; Dancy G; Short D; Seckl MJ; Swerdlow A J Clin Oncol; 2015 Feb; 33(5):472-8. PubMed ID: 25547507 [TBL] [Abstract][Full Text] [Related]
8. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia. Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037 [TBL] [Abstract][Full Text] [Related]
9. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India. Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171 [TBL] [Abstract][Full Text] [Related]
10. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia]. Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278 [No Abstract] [Full Text] [Related]
11. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709 [TBL] [Abstract][Full Text] [Related]
12. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia]. Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279 [No Abstract] [Full Text] [Related]
13. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia. Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM Int J Gynecol Cancer; 2010 Nov; 20(8):1424-8. PubMed ID: 21051988 [TBL] [Abstract][Full Text] [Related]
14. A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group. Faaborg L; Niemann I; Ostenfeld EB; Hansen ES; Sunde L; Lindegaard JC Acta Oncol; 2016; 55(2):234-9. PubMed ID: 26106854 [TBL] [Abstract][Full Text] [Related]
15. Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy. Gadducci A; Cosio S; Fanucchi A; Tana R; Manacorda S; Pistolesi S; Strigini FL Anticancer Res; 2016 Jul; 36(7):3477-82. PubMed ID: 27354611 [TBL] [Abstract][Full Text] [Related]
16. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia. Lurain JR; Schink JC J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816 [TBL] [Abstract][Full Text] [Related]